Message from the Chairman
Increasingly stringent International Pharmaceutical regulations dictate the need for consistent quality standards at all stages of industrial production. In order to address this situation, IPS has created a completely dedicated division, focused on R&D and industrial production of SURINERTS® Pharmaceutical Sugar Spheres, which is in compliance with current international requirements. IPS’s corporate initiative aims to develop our strength in technological concerns, improving quality and range of products.
This initiative is founded on over 35 years of leadership, the highest quality achievements and dedicated contributions of our employees in the field of controlled release oral pharmaceutical products and critical excipients production. We will continue to assure our current and future customers the highest quality and performance from IPS products and services.